» Authors » Adolf W Karchmer

Adolf W Karchmer

Explore the profile of Adolf W Karchmer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 5961
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karchmer A, Kaufman N, Park S, Modi R, Abdul-Azim A, van den Berg P, et al.
Clin Infect Dis . 2025 Mar; PMID: 40066816
Background: Staphylococcus aureus bacteremia in patients with cardiac implantable electronic devices (CIED) is often associated with infective endocarditis (CIED-IE). The CIED-IE diagnosis is syndromic. Diagnostic uncertainty is common. Frequently, these...
2.
Marinacci L, Li A, Tsay A, Benarroch Y, Hill K, Karchmer A, et al.
J Addict Med . 2024 Oct; 18(5):586-594. PMID: 39356621
Background: Patients who undergo cardiac surgery for drug use-associated infective endocarditis (DUA-IE) have high rates of readmissions for recurrent endocarditis, substance use disorder (SUD), and septicemia. Our primary objective was...
3.
Bradley J, Bulitta J, Cook R, Yu P, Iwamoto C, Hesse E, et al.
Clin Infect Dis . 2024 Feb; 78(6):1451-1457. PMID: 38412060
Background: The high mortality of systemic anthrax is likely a consequence of the severe central nervous system inflammation that occurs in anthrax meningitis. Effective treatment of such infections requires, at...
4.
van der Vaart T, Bossuyt P, Durack D, Baddour L, Bayer A, Durante-Mangoni E, et al.
Clin Infect Dis . 2024 Feb; 78(4):922-929. PMID: 38330166
Background: The 2023 Duke-International Society of Cardiovascular Infectious Diseases (ISCVID) criteria for infective endocarditis (IE) were introduced to improve classification of IE for research and clinical purposes. External validation studies...
5.
Bower W, Yu Y, Person M, Parker C, Kennedy J, Sue D, et al.
MMWR Recomm Rep . 2023 Nov; 72(6):1-47. PMID: 37963097
This Report Updates Previous Cdc Guidelines And Recommendations On Preferred Prevention And Treatment Regimens Regarding Naturally Occurring Anthrax. Also Provided Are A Wide Range Of Alternative Regimens To First-line Antimicrobial...
6.
Fowler V, Durack D, Selton-Suty C, Athan E, Bayer A, Chamis A, et al.
Clin Infect Dis . 2023 May; 77(4):518-526. PMID: 37138445
The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular...
7.
Parker C, Karchmer A, Fisher M, Muhammad K, Yu P
Clin Infect Dis . 2022 Oct; 75(Suppl 3):S417-S431. PMID: 36251549
Background: Bacillus anthracis, the causative agent for anthrax, poses a potential bioterrorism threat and is capable of causing mass morbidity and mortality. Antimicrobials are the mainstay of postexposure prophylaxis (PEP)...
8.
Branch-Elliman W, Sturgeon D, Karchmer A, Mull H
Open Forum Infect Dis . 2021 Oct; 8(7):ofab172. PMID: 34631923
Inpatients with culture-positive diabetic foot infections are at elevated risk for subsequent invasive infection with the same causative organism. In outpatients with index diabetic foot ulcers, we found that wound...
9.
Palmeri N, Kramer D, Karchmer A, Zimetbaum P
JACC Clin Electrophysiol . 2021 Jun; 7(6):811-824. PMID: 34167758
Cardiovascular implantable electronic device (CIED) infections are morbid, costly, and difficult to manage. This review explores the pathophysiology, diagnosis, and management of CIED infections. Diagnostic accuracy has been improved through...
10.
Jhaveri V, Sullivan C, Ward A, Giurini J, Karchmer A, Stillman I, et al.
J Am Podiatr Med Assoc . 2021 Feb; 112(6). PMID: 33630067
Background: Diabetic foot osteomyelitis is a common infection where treatment involves multiple services, including infectious diseases, podiatry, and pathology. Despite its ubiquity in the hospital, consensus on much of its...